|
FAM3D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.55707999999199E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.364300E-03 |
| Normal-vs-Stage2 |
2.054400E-01 |
| Normal-vs-Stage3 |
1.216170E-01 |
| Normal-vs-Stage4 |
4.267000E-01 |
| Stage1-vs-Stage2 |
6.376000E-01 |
| Stage1-vs-Stage3 |
5.954200E-01 |
| Stage1-vs-Stage4 |
5.346400E-02 |
| Stage2-vs-Stage3 |
9.941000E-01 |
| Stage2-vs-Stage4 |
4.056000E-01 |
| Stage3-vs-Stage4 |
3.258000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.622390E-04 |
| Normal-vs-AfricanAmerican |
4.633700E-02 |
| Normal-vs-Asian |
2.466200E-01 |
| Caucasian-vs-AfricanAmerican |
5.112000E-02 |
| Caucasian-vs-Asian |
3.651400E-01 |
| AfricanAmerican-vs-Asian |
2.871000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.407210E-04 |
| Normal-vs-Female |
8.783700E-03 |
| Male-vs-Female |
2.491200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.937700E-02 |
| Normal-vs-Extreme_Weight |
5.560300E-03 |
| Normal-vs-Obese |
4.150100E-02 |
| Normal-vs-Extreme_Obese |
2.345400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.106200E-01 |
| Normal_Weight-vs-Obese |
1.462760E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.617960E-01 |
| Extreme_Weight-vs-Obese |
4.302000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.034600E-01 |
| Obese-vs-Extreme_Obese |
9.684800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.376800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.850000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.044200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.799210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.796200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.585500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.910200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.065400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.126800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.511200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.009720E-04 |
| Normal-VS-Type2 PRCC |
6.775700E-02 |
| Normal-VS-KIRP CIMP |
2.179800E-04 |
| Normal-VS-Unclassified PRCC |
2.404800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.030400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.66669999998892E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
1.005800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.288320E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.104400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.119900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.865600E-02 |
| Normal-vs-N1 |
1.596400E-01 |
| Normal-vs-N2 |
5.153000E-01 |
| N0-vs-N1 |
3.318800E-01 |
| N0-vs-N2 |
4.085900E-02 |
| N1-vs-N2 |
1.272610E-01 |
|
|
